| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 医药代理(元) | 226,148,427.20 | 440,515,432.12 | 203,253,981.44 | 430,293,841.54 |
| 医药技术服务(元) | - | - | 10,849,056.60 | 4,761,297.00 |
| 医药制造(元) | 110,037,357.36 | 268,786,820.29 | 180,842,085.06 | 325,015,682.33 |
| 医药技术服务及技术转让(元) | 10,305,411.81 | 10,866,218.20 | - | - |
| 营业成本(元) | ||||
| 医药代理(元) | 99,312,868.59 | 188,520,321.15 | 87,556,784.88 | 182,385,255.02 |
| 医药技术服务(元) | - | - | 4,055,471.80 | 310,212.60 |
| 医药制造(元) | 54,713,917.06 | 119,685,549.15 | 59,930,238.81 | 116,947,987.66 |
| 医药技术服务及技术转让(元) | 5,087,611.32 | 4,072,633.40 | - | - |
| 毛利(元) | ||||
| 医药代理(元) | 126,835,558.61 | 251,995,110.97 | 115,697,196.56 | 247,908,586.52 |
| 医药技术服务(元) | - | - | 6,793,584.80 | 4,451,084.40 |
| 医药制造(元) | 55,323,440.30 | 149,101,271.14 | 120,911,846.25 | 208,067,694.67 |
| 医药技术服务及技术转让(元) | 5,217,800.49 | 6,793,584.80 | - | - |
| 毛利率(%) | ||||
| 医药代理(%) | 56.09 | 57.20 | 56.92 | 57.61 |
| 医药技术服务(%) | - | - | 62.62 | 93.48 |
| 医药制造(%) | 50.28 | 55.47 | 66.86 | 64.02 |
| 医药技术服务及技术转让(%) | 50.63 | 62.52 | - | - |
| 收入构成(%) | ||||
| 医药代理(%) | 65.27 | 61.17 | 51.46 | 56.61 |
| 医药技术服务(%) | - | - | 2.75 | 0.63 |
| 医药制造(%) | 31.76 | 37.32 | 45.79 | 42.76 |
| 医药技术服务及技术转让(%) | 2.97 | 1.51 | - | - |
| 毛利构成(%) | ||||
| 医药代理(%) | 67.69 | 61.78 | 47.53 | 53.84 |
| 医药技术服务(%) | - | - | 2.79 | 0.97 |
| 医药制造(%) | 29.53 | 36.55 | 49.68 | 45.19 |
| 医药技术服务及技术转让(%) | 2.78 | 1.67 | - | - |